首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Breast cancer-targets and therapy

缩写:

ISSN:1179-1314

e-ISSN:1179-1314

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引617
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yuxin Cai,Yanbo Li,Wenqi Wang et al. Yuxin Cai et al.
Objective: To explore the difference between triple-negative breast cancer (TNBC) and non-triple-negative breast cancer (non-TNBC) based on multi-parametric MRI imaging features and construct a prediction model to identif...
Özgür Agdoğan,Sibel Gürdal Özkan Özgür Agdoğan
Objective: This study aims to evaluate the simultaneous implant and dermal flap technique for breast reconstruction following skin-sparing total mastectomy in breast carcinoma patients, assessing both oncological and aest...
Dehui Li,Xukuo Liu,Huanfang Fan et al. Dehui Li et al.
Purpose: Through network pharmacological prediction and in vitro experimental verification, the mechanism of action of Lianqiao Jinbei Decoction (LJD) in inhibiting HER2-positive breast cancer cells was clarified, providi...
Wenhui Ma,Lu Yang,Yu Zhang et al. Wenhui Ma et al.
The heterogeneity of the tumor microenvironment (TME) in breast cancer significantly influences therapeutic response and prognosis, yet noninvasive evaluation remains a clinical challenge. Dynamic contrast-enhanced magnetic resonance imagin...
Anna Ter-Zakarian,Alex Agelidis,Mohammed Jaloudi Anna Ter-Zakarian
Male breast cancer (MBC) is a rare condition, comprising less than 1% of all breast cancer cases. This review examines the epidemiology, risk factors, clinical presentation, diagnostic approaches, and treatment strategies for MBC in both ea...
Zhimin Chen,Pengjun Xie,Qihai Chen et al. Zhimin Chen et al.
Combining cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6 inhibitors) with cyclin-dependent proteins can reduce the formation of cyclin D-CDK4/6 complexes, resulting in the inactivation of downstream genes and suppression of cell prolife...
Jia-Yi Huang,Yan Zhang,Cai-Wen Du Jia-Yi Huang
Purpose: To explore the efficacy and safety of continuous administration of anlotinib combined with oral vinorelbine in refractory human epidermal growth factor-2 (HER2) negative advanced breast cancer (ABC). ...
Rachel Sze Jen Goh,Bryan Chong,Selvie Yeo et al. Rachel Sze Jen Goh et al.
Background: Interval breast cancers (IBCs) are detected between regular mammographic screenings after an initially negative result. Studies have shown that the prognosis of IBCs is similar to that of unscreened symptomati...
Alex Agelidis,Anna Ter-Zakarian,Mohammed Jaloudi Alex Agelidis
Triple-negative breast cancer (TNBC) represents a particularly aggressive and heterogeneous subtype of breast cancer, associated with poor prognosis and limited treatment options. This review delves into the rising incidence of TNBC, partic...
Kexin Zhao,Jun Zhang,Zhe Yang et al. Kexin Zhao et al.
Breast cancer (BC) is the most common type of cancer among women worldwide. A large number of studies have found that the high expression or dysregulation of cyclin-dependent protein kinases (CDKs) is closely associated with breast cancer. ...